January 28, 2025 · Form 4 insider transaction
Finney Kevin bought 190,800 shares of Vaxart Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The shares subject to this option shall vest annually over three years from the vesting commencement date of January 28, 2025, the date of the grantee's appointment as a director of Vaxart, Inc.